Read the full stored bill text
Wisconsin Legislature: AB400: Bill Text
Skip navigation
Home
Documents
Senate
Assembly
Committees
Service Agencies
Docs
Options
Help
2025 Biennium
Statutes
Admin. Rules
Indices
Miscellaneous
Archives
Home
Bill, Rule, and Appointment Histories
Senators
Representatives
Committees
Text of Introduced Proposals
Amendment Text
Acts
Veto Messages
Enrolled Bills
Votes
Assembly and Senate Floor Calendars
Schedule of Committee Activities
Assembly and Senate Journals
Committee Records (ROCPs)
Legislative Rules
All Session-Related Documents
Subject Index to Acts
Subject Index to Legislation
Subject Index to Journals
Author Index to Legislation
Subject Index to Clearinghouse Rules
Miscellaneous Budget Documents
Executive Orders
Rulings of the Chair
Wisconsin Supreme Court Rules
Opinions of the Attorney General
Town Law Forms
Law
Districts
Session
Drafting Files
Feeds
Preferences
Show tree
Hide tree
Feedback
Help
Home
Senate Home
Senators
Committees
Session
Chief Clerk
Sergeant at Arms
Civics Education
Human Resources
Assembly Home
Representatives
Committees
Session
Chief Clerk
Sergeant at Arms
Human Resources
Schedule
Joint
Senate
Assembly
Study
Legislative Audit Bureau
Legislative Council
Legislative Fiscal Bureau
Legislative Human Resources Office
Legislative Reference Bureau
Legislative Technology Services Bureau
Menu
»
2025
»
Related Documents
»
Proposal Text
»
AB400: Bill Text
Up
Up
2025 - 2026 LEGISLATURE
LRB-4270/1
KRP&JPC:skw
2025 ASSEMBLY BILL 400
August 29, 2025 - Introduced by Representatives
Nedweski
,
Steffen
,
Allen
,
Behnke
,
Brill
,
Dittrich
,
Green
,
Knodl
,
Kreibich
,
Maxey
,
Murphy
,
Mursau
,
O'Connor
,
Penterman
,
Piwowarczyk
and
Wichgers
, cosponsored by Senators
Hutton
,
Kapenga
,
Bradley
and
Nass
. Referred to Committee on Judiciary.
AB400,1,2
1
An Act
to create
895.039 of the statutes;
relating to:
a civil cause of action for
2
a minor injured by a gender transition procedure.
Analysis by the Legislative Reference Bureau
This bill establishes a civil cause of action against a health care provider who performs a gender transition procedure, as defined in the bill, on an individual who is under 18 years of age and who is injured, including any physical, psychological, emotional, or physiological injury, by the gender transition procedure or related treatment or the aftereffects of the gender transition procedure or related treatment. Under the bill, such an action must be commenced before the individual attains the age of 33 years.
The bill provides that it is a defense to an action under the bill if all of the following occur before a health care provider performs a gender transition procedure on an individual who is under 18 years of age:
1. The health care provider documents the individual’s perceived gender or perceived sex for at least two continuous years, and the individual’s perceived gender or perceived sex is invariably inconsistent with the individual’s biological sex throughout the two-year period.
2. To the extent that the individual suffers from a mental health concern, at least one mental health professional and one other health care provider certifies in writing that the gender transition procedure is the only way to treat the mental health concern.
3. At least one mental health professional and one other health care provider certifies in writing that the individual suffers from no other mental health concerns.
4. The health care provider receives the voluntary and informed consent of the individual and the individual’s parent or legal guardian by providing them, both orally and in writing, with a notice, the contents are which are prescribed in the bill, at least 30 days before the first treatment of the gender transition procedure and during every subsequent medical visit for treatment during the following six months.
The people of the state of Wisconsin, represented in senate and assembly, do enact as follows:
AB400,1
1
Section
1
.
895.039 of the statutes is created to read:
AB400,2,3
2
895.039
Performing gender transition procedures on minors;
3
liability.
(1)
Definitions.
In this section:
AB400,2,6
4
(a) 1. “Gender transition procedure” means a medical or surgical service,
5
including a physician’s service, inpatient or outpatient hospital service, or
6
prescribed drug, related to gender transition that seeks to do any of the following:
AB400,2,8
7
a. Alter or remove an individual’s physical or anatomical characteristics or
8
features that are typical for the individual’s biological sex.
AB400,2,15
9
b. Instill or create for an individual physiological or anatomical characteristics
10
that resemble a sex different from the individual’s biological sex, including a
11
medical service that provides puberty-blocking drugs, cross-sex hormones, or
12
another mechanism to promote the development of feminizing or masculinizing
13
features in a sex different from the individual’s biological sex, or genital or
14
nongenital gender reassignment surgery performed for the purpose of assisting an
15
individual with a gender transition.
AB400,3,2
1
2. Notwithstanding subd. 1., “gender transition procedure” does not include
2
any of the following:
AB400,3,7
3
a. A service provided to an individual born with a medically verifiable
4
disorder of sexual development, including an individual with external biological sex
5
characteristics that are irresolvably ambiguous, such as an individual born with
6
46,XX chromosomes with virilization, with 46,XY chromosomes with
7
undervirilization, or having both ovarian and testicular tissue.
AB400,3,12
8
b. A service provided to an individual when a physician has diagnosed a
9
sexual development disorder and the physician has determined through genetic or
10
biochemical testing that the individual does not have the normal sex chromosome
11
structure, sex steroid hormone production, or sex steroid hormone action for a
12
biological male or biological female.
AB400,3,16
13
c. The treatment of an infection, injury, disease, or disorder that is caused or
14
exacerbated by the performance of a gender transition procedure, regardless of
15
whether the gender transition procedure was performed in accordance with state or
16
federal law.
AB400,3,20
17
d. A procedure undertaken because an individual suffers from a physical
18
disorder, physical injury, or physical illness that would, as certified by a physician,
19
place the individual in imminent danger of death or impairment of major bodily
20
function unless surgery is performed.
AB400,3,21
21
(b) “Health care provider” has the meaning given in s. 146.81 (1) (a) to (hp).
AB400,3,22
22
(c) “Mental health professional” means any of the following:
AB400,4,2
1
1. A physician licensed under subch. II of ch. 448 who specializes in
2
psychiatry.
AB400,4,3
3
2. A psychologist licensed under ch. 455.
AB400,4,4
4
3. A professional counselor licensed under ch. 457.
AB400,4,5
5
4. A marriage and family therapist licensed under ch. 457.
AB400,4,6
6
5. A social worker certified or licensed under ch. 457.
AB400,4,7
7
(d) “Minor” means an individual who is under 18 years of age.
AB400,4,14
8
(2)
Civil causes of action.
A health care provider who performs a gender
9
transition procedure on a minor is liable to the minor if the minor is injured,
10
including any physical, psychological, emotional, or physiological injury, by the
11
gender transition procedure or related treatment or the aftereffects of the gender
12
transition procedure or related treatment. The minor, or the minor’s parent, legal
13
guardian, or legal representative, may bring a civil action against the health care
14
provider for any of the following damages:
AB400,4,15
15
(a) Declaratory or injunctive relief.
AB400,4,16
16
(b) Compensatory damages.
AB400,4,17
17
(c) Punitive damages.
AB400,4,18
18
(d) If the prevailing party, reasonable attorney fees and costs.
AB400,4,22
19
(3)
Limitation of actions.
An action under this section shall be commenced
20
before the minor has attained the age of 33 years or, if the minor dies before
21
attaining the age of 33 years, the date on which the minor would have attained the
22
age of 33 years.
AB400,5,2
23
(4)
Safe harbor.
(a) It is a defense to an action brought under this section if,
1
before a health care provider performs a gender transition procedure on a minor, all
2
of the following occur:
AB400,5,6
3
1. The health care provider documents the minor’s perceived gender or
4
perceived sex for at least 2 continuous years, and the minor’s perceived gender or
5
perceived sex is invariably inconsistent with the minor’s biological sex throughout
6
the 2-year period.
AB400,5,10
7
2. To the extent that the minor suffers from a mental health concern, at least
8
2 health care providers, including at least one mental health professional, certifies
9
in writing that the gender transition procedure is the only way to treat the mental
10
health concern.
AB400,5,15
11
3. At least 2 health care providers, including at least one mental health
12
professional, certifies in writing that the minor suffers from no mental health
13
concerns other than the concern described under subd. 2., including depression, an
14
eating disorder, autism, attention deficit hyperactivity disorder, intellectual
15
disability, or a psychotic disorder.
AB400,5,17
16
4. The health care provider receives the voluntary and informed consent of
17
the minor and the minor’s parent or legal guardian as provided in par. (b).
AB400,5,23
18
(b) Consent to a gender transition procedure is voluntary and informed under
19
par. (a) 4. only if, at least 30 days before the first treatment of the gender transition
20
procedure and during every subsequent medical visit for treatment during the
21
following 6 months, the minor and the minor’s parent or legal guardian is provided
22
with the following notice, both orally and in writing in at least 14-point type in a
23
proportional font:
AB400,6,1
1
NOTICE
AB400,6,8
2
If your child begins one of these treatments, it may actually worsen the
3
discordance and thus increase the likelihood that your child will need additional
4
and more serious interventions to address the worsening condition. For example, if
5
your child begins socially transitioning or taking puberty blockers, that treatment
6
may significantly increase the likelihood that your child’s discordance will worsen
7
and lead to your child eventually seeking cross-sex hormones or even surgery to
8
remove some of your child’s body parts.
AB400,6,12
9
Sweden, Finland, and the United Kingdom have conducted systematic reviews
10
of evidence and concluded that there is no evidence that the potential benefits of
11
puberty blockers and cross-sex hormones for this purpose outweigh the known or
12
assumed risks.
AB400,6,17
13
Medical authorities in Sweden, Finland, and the United Kingdom have since
14
recommended psychotherapy as the first line of treatment for youth gender
15
dysphoria, with drugs and surgeries reserved as a measure of last resort. Medical
16
authorities in France have advised “great caution” when prescribing hormones for
17
gender dysphoria.
AB400,6,23
18
There are people who underwent gender transition treatments as minors and
19
later regretted that decision and the physical harm that these treatments caused,
20
and the total percentage of people who experience this regret is unknown. Some
21
estimate that the rate is below 2 percent, but that estimate is based on studies done
22
on adults who transitioned as adults or on minors who transitioned under highly
23
restrictive and controlled conditions.
AB400,7,7
1
Sometimes gender transition treatments have been proposed as a way to
2
reduce the chances of a minor committing suicide due to discordance between the
3
minor’s sex and his or her perception, but the rates of actual suicide from this
4
discordance remain extremely low. Furthermore, as recognized by health
5
authorities in Europe, there is no evidence that suicidality is caused by
6
“unaffirmed” gender or that gender transition treatments are causally linked to a
7
reduction in serious suicidal attempts or ideations.
AB400,7,8
8
For puberty blockers:
AB400,8,2
9
Puberty blockers are not approved for this purpose by the U.S. food and drug
10
administration, which is the federal agency that determines which drugs are safe
11
and effective for humans to use. Claims about puberty blockers’ safety and efficacy
12
are based on their use for precocious puberty, a different condition in which normal
13
puberty is allowed to resume once the patient reaches the appropriate age. Studies
14
on the benefits of using puberty blockers for gender dysphoria are notoriously weak.
15
Puberty blockers are not fully reversible because, among other risks, puberty
16
blockers may intensify a minor’s discordance and cause it to persist. Puberty
17
blockers increase the risk of your child being sterilized, meaning that he or she will
18
never be able to have children. Puberty blockers may also cause diminished bone
19
density for your child, increasing the risk of fracture and early osteoporosis.
20
Puberty blockers may also prevent your child from ever being able to engage in
21
sexual activity or achieve orgasm for the rest of your child’s life. There is no
22
research on the long-term risks to minors of persistent exposure to puberty
1
blockers. The full effects of puberty blockers on brain development and cognition
2
are unknown.
AB400,8,3
3
For cross-sex hormones:
AB400,8,17
4
The use of cross-sex hormones in males is associated with numerous health
5
risks, such as thromboembolic disease, including blood clots; cholelithiasis,
6
including gallstones; coronary artery disease, including heart attacks;
7
macroprolactinoma, which is a tumor of the pituitary gland; cerebrovascular
8
disease, including stroke; hypertriglyceridemia, which is an elevated level of
9
triglycerides in the blood; breast cancer; and irreversible infertility. The use of
10
cross-sex hormones in females is associated with risks of erythrocytosis, which is an
11
increase in red blood cells; severe liver dysfunction; coronary artery disease,
12
including heart attack; hypertension; and increased risk of breast and uterine
13
cancer. Once a minor begins cross-sex hormones, the minor may need to continue
14
taking those hormones for many years and possibly for the remainder of the minor’s
15
life. The cost of these hormones may be tens of thousands of dollars. If the use of
16
cross-sex hormones leads to surgery, the total cost of transitioning may exceed
17
$100,000.
AB400,8,18
18
For surgical procedures:
Down
Down
/2025/related/proposals/ab400
true
proposaltext
/2025/related/proposals/ab400
proposaltext/2025/REG/AB400
proposaltext/2025/REG/AB400
section
true
Menu
»
2025
»
Related Documents
»
Proposal Text
»
AB400: Bill Text
×
Details for
PDF view
Link
(Permanent link)
Bookmark this location
View toggle
Go to top of document
Search in this chapter
Search in this section
Search in this agency
Search in this chapter group
Search in this chapter
Search in this section
Cross references for section
Acts affecting this section
References to this
1970 Statutes Annotations
Appellate Court Citations
Administrative Code Index
Reference lines
Clear highlighting